Chronic Kidney Disease Progression Risk in Patients With Diabetes Mellitus Using Dihydropyridine Calcium Channel Blockers: A Nationwide, Population-Based, Propensity Score Matching Cohort Study

Background: Whether diabetes mellitus (DM) patients with chronic kidney disease (CKD) can glean individual renal benefit from dihydropyridine calcium channel blockers (DCCBs) remains to be determined. We conducted a nationwide, population-based, propensity score matching cohort study to examine the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shih-Yi Lin, Cheng-Li Lin, Cheng-Chieh Lin, Wu-Huei Hsu, Chung-Y. Hsu, Chia-Hung Kao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-03-01
coleção:	Frontiers in Pharmacology
Assuntos:	NHIRD: national health insurance diabetes mellitus (DM) chronic kidney disease (CKD) dihydropyridine calcium channel blockers (DCCBs) end-stage renal disease (ESRD)
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2022.786203/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!